• Mashup Score: 3

    Join Akl Fahed MD, MHP, FACC and Pradeep Natarajan MD, FACC as they discuss using genetic testing to inform treatment planning and care management of patients with lipids disorders. Your browser doesn’t support HTML5 audio. Here is a link to the audio instead. Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia,…

    Tweet Tweets with this article
    • Join Drs. @aklfahed and @pnatarajanmd as they discuss using genetic testing to inform treatment planning and care management of patients with #cvLipids disorders. Listen to the podcast episode here: https://t.co/ylhSF2wwOx #cvGenetics #CardioTwitter

  • Mashup Score: 1

    Prevention and Health Promotion The world of cardiovascular prevention is exploding with respect to new therapies in lipidology, cardiometabolic disease and weight loss. The Prevention and Health Promotion Learning Pathway at ACC.23/WCC provides attendees with the key data on these topics in fun, innovative sessions. Given that cardiovascular prevention is at the core of so many disciplines…

    Tweet Tweets with this article
    • The 🌎 of #cvPrev is exploding w/ new therapies in #cvLipids, #cvMetabolic disease & weight loss. Discover what's in store for the Prevention & Health Promotion Learning Pathway at #ACC23/#WCCardio from Topic Coordinator Dr. @ErinMichos: https://t.co/4uTxXQeA0X #CardioTwitter https://t.co/S3ZbNzLqnw

  • Mashup Score: 3

    A 66-year-old male with a history of hyperlipidemia, hypertension, degenerative joint disorder, and gastroesophageal reflux disease (GERD), presented with shortness of breath and palpitation. Baseline electrocardiogram (ECG) showed sinus rhythm with T wave changes that could be related to lateral wall ischemia (Figure 1). Figure 1: Baseline ECG sinus bradycardia with T wave abnormalities due to…

    Tweet Tweets with this article
    • A 66 y/o male w/ a history of #cvLipids, #Hypertension, degenerative joint disorder, and GERD, presented w/ shortness of breath and palpitation. What is the most appropriate next step? Find out more and vote here: https://t.co/1ABaZyGuqn #ACCEd https://t.co/bNrfht70jR

  • Mashup Score: 7

    Quick Takes The 2022 NLA scientific statement on statin intolerance provides an updated definition of statin intolerance which now classifies intolerance as either partial or complete, taking into consideration the ability to achieve therapeutic targets on maximally tolerated statin dosing. Statin intolerance exists as a spectrum of muscle related symptoms, which may or may not be related to…

    Tweet Tweets with this article
    • #Statin intolerance exists as a spectrum of muscle related symptoms and a significant nocebo effect. Read more about the 2022 @nationallipid scientific statement on statin intolerance here: https://t.co/HvNPyBhYk7 #cvLipids #CVD https://t.co/a1R6EGsIpU

  • Mashup Score: 2

    The ACC has collaborated with Medscape to create two Centers of Excellence on the topics of Cardiovascular Risk Reduction and Heart Failure. This collaboration will expand the reach of expert information, including best practices in CV medicine, to improve patient care. June 13, 2022 Heart Failure With Reduced Ejection Fraction: Advances in ManagementJaved Butler, MD, MPH, MBA; Biykem…

    Tweet Tweets with this article
    • In a new ACC & @Medscape collaborative piece, Drs. @PamTaubMD and Steven E. Nissen discuss the future of #cvLipids management. Get more information here: https://t.co/82NI3VXt5C #CardioTwitter